3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
Specimen Handling
6
fludarabine
5
Whole-Body Irradiation
5
Cytarabine
5
Cyclophosphamide
5
venetoclax
4
Methotrexate
4
Biopsy
4
merphos
3
fludarabine phosphate
3
blinatumomab
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
prednylidene
2
deltacortene
2
calaspargase pegol
2
Thiotepa
2
Tacrolimus
2
Stem Cell Transplantation
2
Spinal Puncture
2
Rituximab
2
Prednisone
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Filgrastim
2
CT-P10
2
Busulfan
2
Asparaginase
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Biphenotypic, Acute
×
revumenib
×
30 days
×
Clear all
No trials found.